Safety and efficacy of immune checkpoint inhibitors in cancer patients and pre-existing autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer.

Authors

Wint Yan Aung

Northwell Health, Manhasset, NY

Wint Yan Aung , Chung-Shien Lee , Jaclyn Morales , Nina Kohn , Husneara Rahman , Nagashree Seetharamu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9053)

DOI

10.1200/JCO.2023.41.16_suppl.9053

Abstract #

9053

Poster Bd #

Abstract Disclosures

FEATURED

Safety and efficacy of immune checkpoint inhibitors in cancer patients and pre-existing autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer.

Authors

Wint Yan Aung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Poster Details

Meeting

Session Type

Session Title

Track

Sub Track

Citation

DOI

Abstract #

Poster Bd #

Similar Posters

Poster

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.

Poster

Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients (pts) with cardiac metastases (mets) from solid tumors.

Poster

The impact of pembrolizumab on patients with pre-existing autoimmune diseases.

Poster

Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after failure on first-line immune checkpoint inhibitor combination therapy: Initial efficacy and safety results from VARGADO Cohort C.